JACQUES E. GIELEN
Impact in
- Pharmacology top 0.1%
- Pharmacogenetics and Drug Metabolism
- Cancer Research top 5%
- NF-κB Signaling Pathways
- Carcinogens and Genotoxicity Assessment
Papers in
- Pharmacology 39
- Pharmacogenetics and Drug Metabolism 38
-
- NF-κB Signaling Pathways 4
- Carcinogens and Genotoxicity Assessment 2
- Co-authors
- Daniel W. Nebert (12 shared papers)Francine M. Goujon (8 shared papers)Jacques VAN CANTFORT (24 shared papers)Vincent Bours (19 shared papers)Jean DE GRAEVE (12 shared papers)Marie‐Paule Merville (17 shared papers)Pierre G. Kremers (22 shared papers)Alain Chariot (10 shared papers)
- Journals
- European Journal of Biochemistry (10 papers)Biochemical Pharmacology (9 papers)Journal of Biological Chemistry (7 papers)Biochemical and Biophysical Research Communications (5 papers)Oncogene (5 papers)
- Partner nations
- BelgiumUnited StatesFrance
In The Last Decade
JACQUES E. GIELEN
94 papers receiving 3.6k citations
Peers
Comparison fields: 5 of 80
- Pharmacology 1.2k
- Cancer Research 296
- Health, Toxicology and Mutagenesis 213
- Oncology 215
- Nephrology 66
Countries citing papers authored by JACQUES E. GIELEN
This map shows the geographic impact of JACQUES E. GIELEN's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JACQUES E. GIELEN with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JACQUES E. GIELEN more than expected).
Fields of papers citing papers by JACQUES E. GIELEN
This network shows the impact of papers produced by JACQUES E. GIELEN. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JACQUES E. GIELEN. The network helps show where JACQUES E. GIELEN may publish in the future.
Co-authors
The 25 scholars most cited alongside JACQUES E. GIELEN, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 96 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 397 | |
| 2 | 1977 | 254 | |
| 3 | 1972 | 228 | |
| 4 | 1972 | 183 | |
| 5 | Genetic expression of aryl hydrocarbon hydroxylase induction. IV. Interaction of various compounds with different forms of cytochrome P-450 and the effect on benzo(a)pyrene metabolism in vitro. | 1972 | 172 |
| 6 | 1981 | 169 | |
| 7 | 1974 | 126 | |
| 8 | 1971 | 102 | |
| 9 | 1999 | 102 | |
| 10 | 1975 | 97 | |
| 11 | 1998 | 92 | |
| 12 | 2003 | 86 | |
| 13 | 1981 | 76 | |
| 14 | 2004 | 75 | |
| 15 | 1985 | 68 | |
| 16 | 1975 | 67 | |
| 17 | 1971 | 63 | |
| 18 | 1973 | 58 | |
| 19 | 2003 | 58 | |
| 20 | 1971 | 56 |
About JACQUES E. GIELEN
JACQUES E. GIELEN is a scholar working on Pharmacology, Cancer Research, Genetics, Surgery and Oncology, having authored 96 papers that have together received 4.0k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (38 papers), Cholesterol and Lipid Metabolism (10 papers), NF-κB Signaling Pathways (4 papers), Virus-based gene therapy research (4 papers), Cancer-related Molecular Pathways (3 papers), Estrogen and related hormone effects (3 papers), Steroid Chemistry and Biochemistry (2 papers) and Carcinogens and Genotoxicity Assessment (2 papers). The work is most often cited by research in Pharmacology (1.2k citations), Cancer Research (296 citations), Health, Toxicology and Mutagenesis (213 citations), Oncology (215 citations) and Nephrology (66 citations). JACQUES E. GIELEN has collaborated with scholars based in Belgium, United States and France. Frequent co-authors include Daniel W. Nebert, Francine M. Goujon, Jacques VAN CANTFORT, Vincent Bours, Jean DE GRAEVE, Marie‐Paule Merville, Pierre G. Kremers, Alain Chariot, Nebert Dw and Mohamed Bentires‐Alj. Their work appears in journals such as European Journal of Biochemistry, Biochemical Pharmacology, Journal of Biological Chemistry, Biochemical and Biophysical Research Communications and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.